Our Kalamon olives are meticulously handpicked and processed with the utmost care to preserve their rich taste, texture, and nutritional value. Grown under the Mediterranean sun, these premium olives are a staple of the traditional Greek diet and a delicious addition to any meal.

Their natural richness in healthy fats, antioxidants, and vitamins makes them an excellent choice for a balanced lifestyle. Whether enjoyed on their own, in salads, or as part of gourmet recipes, Kalamon olives offer authentic flavor and uncompromising quality.

Ideal for health-conscious consumers and lovers of Mediterranean cuisine, our olives are available in various forms—ready to elevate your dining experience.

Discover the taste of Greece, one olive at a time.

Cannabidiol is completely safe and legal to use, while according to a report by the World Health Organization it offers significant effects and benefits to the individual’s body, while inrecent years it has entered the life of modern man for good thanks to various nutritional supplements ( flour, olives, olive paste, and various others) that are available on the market and mainly instores with selected foods, as at the same time scientists continue to carry out research on its use as an adjuvant treatment for a multitude of mental and physical ailments, some of them are the following:
Autoimmune Diseases, inflammation, chronic pain, epilepsy, Alzheimer’s disease, anxiety disorders, psychoses, multiple sclerosis,The discovery by researchers that the human body somehow produces its own cannabis is considered recent.Cannabidiol interact with the cell receptors of the endocannabinoid system, but without being bound by them, so it manages to strengthen thefunction as well as the coordination of the necessary functions, to effectively protect the body against threats.

Sources:

Elsohly MA, Gul W. Handbook of Cannabis. Oxford, UK: Oxford University, (Constituents of cannabis sativa), 2014.
Vincenzo Di Marzo 1, Fabiana Piscitelli (The Endocannabinoid System and its Modulation by Phytocannabinoids), 2015.
World Health Organization Update of Cannabis and its medical use 37th ECDD (2015) Agenda item 6.2″

May reverse the carcinogenic effects of tobacco and improve lung health
It can help treat seizures
Relieves the symptoms of arthritis
Helps in weight loss and regulates metabolism
It can treat the symptoms of Crohn’s disease
Protects brain function after a stroke
Relieves the symptoms of Parkinson’s disease
Medical use
A 2002 review of the medical literature by François Grottenharmen found that medical use of cannabis had shown positive effects in the treatment of nausea, vomiting, premenstrual syndrome, unintentional weight loss, insomnia and loss of appetite. from chemotherapy. Other relatively well-established evidence suggests the treatment of spasticity in people with multiple sclerosis, pain and in particular neurogenic pain, motor difficulties, asthma and glaucoma. [5]

Preliminary evidence suggests that cannabis-based drugs may be useful in treating adrenal dysfunction, irritable bowel syndrome, migraines, fibromyalgia and related diseases. [6] Medical cannabis use also appears to treat specific symptoms of conditions such as multiple sclerosis [7] and spinal cord injuries [8] [9], exhibiting antispasmodic and muscle relaxant effects, as well as increasing appetite in these patients.

Other medical research suggests that cannabis, or cannabinoids in particular, may be used to treat alcohol abuse [10], arthritis caused by excess collagen [11] [12], asthma [13], atherosclerosis, bipolar disorder 14], post-traumatic syndrome [15], colon cancer [16], HIV-related sensory neuropathy, dystonia [17], epilepsy [18], specific diseases of the digestive system [19], gliomas (brain tumor type) [20], hepatitis C [21], Huntington’s disease, leukemia [22], skin tumors [23], methicillin-resistant strains of Staphylococcus aureus [15] , Parkinson [24], pruritus ani, psoriasis [25], sickle cell disease [26], sleep apnea [27] and anorexia nervosa [28]. A controlled trial in the treatment of Tourette’s syndrome with a drug (Dronabinol) containing an active substance that is synthetically homologous to δ9-tetrahydrocannabinol, the main psychoactive substance in cannabis, showed that patients had a reduction in their symptoms without side effects [29 ] [30], but other research claims that it had no effect on reducing ticks [31]. Patient reports themselves show a reduction in tics with medical cannabis use [32] [33], but long-term, controlled studies are needed to demonstrate this in a larger number of patients.

Many laboratories around the world are doing intensive research to produce drugs based on cannabis ingredients, but they will not have psychotropic effects, ie they will stay away from the area of ​​the brain and will act only on the peripheral receptor to which the non-psychotropic analogues (ie the cannabinoid mimetic molecules modified by the researchers) showing high anti-inflammatory activity. The first such preparation for pain and stress was announced on July 1, 2005 in the journal Nature by researchers at the University of Georgia, and others for epilepsy and multiple sclerosis will follow.

In March 2014, the U.S. Department of Public Health approved the study on medical marijuana, marking a historic milestone in U.S. federal policy. Specifically, the Interdisciplinary Association for the Study of Psychotropic Drugs (MAPS) has been trying for the past 22 years to launch research into the development of medical cannabis-based drugs, and this is the first time since the National Marijuana was licensed for medical use. The Institute on Drug Abuse (NIDA), the only federally regulated marijuana provider in the United States.

May reverse the carcinogenic effects of tobacco and improve lung health
It can help treat seizures
Relieves the symptoms of arthritis
Helps in weight loss and regulates metabolism
It can treat the symptoms of Crohn’s disease
Protects brain function after a stroke
Relieves the symptoms of Parkinson’s disease
Medical use
A 2002 review of the medical literature by François Grottenharmen found that medical use of cannabis had shown positive effects in the treatment of nausea, vomiting, premenstrual syndrome, unintentional weight loss, insomnia and loss of appetite. from chemotherapy. Other relatively well-established evidence suggests the treatment of spasticity in people with multiple sclerosis, pain and in particular neurogenic pain, motor difficulties, asthma and glaucoma. [5]

Preliminary evidence suggests that cannabis-based drugs may be useful in treating adrenal dysfunction, irritable bowel syndrome, migraines, fibromyalgia and related diseases. [6] Medical cannabis use also appears to treat specific symptoms of conditions such as multiple sclerosis [7] and spinal cord injuries [8] [9], exhibiting antispasmodic and muscle relaxant effects, as well as increasing appetite in these patients.

Other medical research suggests that cannabis, or cannabinoids in particular, may be used to treat alcohol abuse [10], arthritis caused by excess collagen [11] [12], asthma [13], atherosclerosis, bipolar disorder 14], post-traumatic syndrome [15], colon cancer [16], HIV-related sensory neuropathy, dystonia [17], epilepsy [18], specific diseases of the digestive system [19], gliomas (brain tumor type) [20], hepatitis C [21], Huntington’s disease, leukemia [22], skin tumors [23], methicillin-resistant strains of Staphylococcus aureus [15] , Parkinson [24], pruritus ani, psoriasis [25], sickle cell disease [26], sleep apnea [27] and anorexia nervosa [28]. A controlled trial in the treatment of Tourette’s syndrome with a drug (Dronabinol) containing an active substance that is synthetically homologous to δ9-tetrahydrocannabinol, the main psychoactive substance in cannabis, showed that patients had a reduction in their symptoms without side effects [29 ] [30], but other research claims that it had no effect on reducing ticks [31]. Patient reports themselves show a reduction in tics with medical cannabis use [32] [33], but long-term, controlled studies are needed to demonstrate this in a larger number of patients.

Many laboratories around the world are doing intensive research to produce drugs based on cannabis ingredients, but they will not have psychotropic effects, ie they will stay away from the area of ​​the brain and will act only on the peripheral receptor to which the non-psychotropic analogues (ie the cannabinoid mimetic molecules modified by the researchers) showing high anti-inflammatory activity. The first such preparation for pain and stress was announced on July 1, 2005 in the journal Nature by researchers at the University of Georgia, and others for epilepsy and multiple sclerosis will follow.

In March 2014, the U.S. Department of Public Health approved the study on medical marijuana, marking a historic milestone in U.S. federal policy. Specifically, the Interdisciplinary Association for the Study of Psychotropic Drugs (MAPS) has been trying for the past 22 years to launch research into the development of medical cannabis-based drugs, and this is the first time since the National Marijuana was licensed for medical use. The Institute on Drug Abuse (NIDA), the only federally regulated marijuana provider in the United States.

Rich, complex taste with a bold aromatic profile
Perfect balance of spice and aged cheese depth
A true delicacy for cheese lovers

Pairing Suggestions

Enjoy it with a glass of red or white dry wine for an elevated tasting experience.
Pairs beautifully with cold Raki, enhancing its robust character.

A must-try for those who appreciate premium, artisanal cheeses!